These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23567149)

  • 1. Designer peptide antagonist of the leptin receptor with peripheral antineoplastic activity.
    Beccari S; Kovalszky I; Wade JD; Otvos L; Surmacz E
    Peptides; 2013 Jun; 44():127-34. PubMed ID: 23567149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward understanding the role of leptin and leptin receptor antagonism in preclinical models of rheumatoid arthritis.
    Otvos L; Shao WH; Vanniasinghe AS; Amon MA; Holub MC; Kovalszky I; Wade JD; Doll M; Cohen PL; Manolios N; Surmacz E
    Peptides; 2011 Aug; 32(8):1567-74. PubMed ID: 21723351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo.
    Catalano S; Leggio A; Barone I; De Marco R; Gelsomino L; Campana A; Malivindi R; Panza S; Giordano C; Liguori A; Bonofiglio D; Liguori A; Andò S
    J Cell Mol Med; 2015 May; 19(5):1122-32. PubMed ID: 25721149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer.
    Otvos L; Kovalszky I; Riolfi M; Ferla R; Olah J; Sztodola A; Nama K; Molino A; Piubello Q; Wade JD; Surmacz E
    Eur J Cancer; 2011 Jul; 47(10):1578-84. PubMed ID: 21353530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a pharmacologically improved peptide agonist of the leptin receptor.
    Otvos L; Terrasi M; Cascio S; Cassone M; Abbadessa G; De Pascali F; Scolaro L; Knappe D; Stawikowski M; Cudic P; Wade JD; Hoffmann R; Surmacz E
    Biochim Biophys Acta; 2008 Oct; 1783(10):1745-54. PubMed ID: 18555805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer.
    Chen X; Zha X; Chen W; Zhu T; Qiu J; Røe OD; Li J; Wang Z; Yin Y
    Biomed Pharmacother; 2013 Feb; 67(1):22-30. PubMed ID: 23199901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The designer leptin antagonist peptide Allo-aca compensates for short serum half-life with very tight binding to the receptor.
    Otvos L; Vetter SW; Koladia M; Knappe D; Schmidt R; Ostorhazi E; Kovalszky I; Bionda N; Cudic P; Surmacz E; Wade JD; Hoffmann R
    Amino Acids; 2014 Apr; 46(4):873-82. PubMed ID: 24366600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentivirus-mediated RNA interference targeting the ObR gene in human breast cancer MCF-7 cells in a nude mouse xenograft model.
    Xue RQ; Gu JC; DU ST; Yu W; Wang Y; Zhang ZT; Bai ZG; Ma XM
    Chin Med J (Engl); 2012 May; 125(9):1563-70. PubMed ID: 22800822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
    Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
    Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-based leptin receptor antagonists for cancer treatment and appetite regulation.
    Otvos L; Kovalszky I; Scolaro L; Sztodola A; Olah J; Cassone M; Knappe D; Hoffmann R; Lovas S; Hatfield MP; Beko G; Zhang S; Wade JD; Surmacz E
    Biopolymers; 2011; 96(2):117-25. PubMed ID: 20564005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells.
    Wu X; Yan Q; Zhang Z; Du G; Wan X
    Oncol Rep; 2012 May; 27(5):1488-96. PubMed ID: 22327423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of adiponectin-derived peptides for inhibition of cancer cell growth and signaling.
    Otvos L; Kovalszky I; Olah J; Coroniti R; Knappe D; Nollmann FI; Hoffmann R; Wade JD; Lovas S; Surmacz E
    Biopolymers; 2015 May; 104(3):156-66. PubMed ID: 25683126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis.
    Endo H; Hosono K; Uchiyama T; Sakai E; Sugiyama M; Takahashi H; Nakajima N; Wada K; Takeda K; Nakagama H; Nakajima A
    Gut; 2011 Oct; 60(10):1363-71. PubMed ID: 21406387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo.
    Rastelli L; Valentino ML; Minderman MC; Landin J; Malyankar UM; Lescoe MK; Kitson R; Brunson K; Souan L; Forenza S; Goldfarb RH; Rabbani SA
    Int J Oncol; 2011 Aug; 39(2):401-8. PubMed ID: 21567086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular mechanism of action of superactive human leptin antagonist (SHLA) and quadruple leptin mutein Lan-2 on human ovarian epithelial cell lines.
    Fiedor E; Gregoraszczuk EŁ
    Cancer Chemother Pharmacol; 2016 Sep; 78(3):611-22. PubMed ID: 27480179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin signaling in breast cancer: an overview.
    Cirillo D; Rachiglio AM; la Montagna R; Giordano A; Normanno N
    J Cell Biochem; 2008 Nov; 105(4):956-64. PubMed ID: 18821585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring leptin antagonism in ophthalmic cell models.
    Scolaro L; Parrino C; Coroniti R; Otvos L; Surmacz E
    PLoS One; 2013; 8(10):e76437. PubMed ID: 24098500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of glucose metabolism in leptin-resistant mouse hearts after acute myocardial infarction through the activation of survival kinase pathways.
    Witham W; Yester K; O'Donnell CP; McGaffin KR
    J Mol Cell Cardiol; 2012 Jul; 53(1):91-100. PubMed ID: 22507542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.